Cutia Therapeutics is a holding company, which engages in the research and development of dermatology treatment solutions and products through its subsidiaries. Its product portfolios include scalp diseases and care, skin diseases and care, localized adipose accumulation management medication, and topical anesthesia. The company was founded by Le Le Zhang on May 15, 2019 and is headquartered in Shanghai, China.